Year None20222021202020192018201720162015201420132012 01.04.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 01.04.2022 Iveric Bio to Present at the H.C. Wainwright BioConnect Virtual Conference 12.13.2021 Iveric Bio Appoints Tony Gibney as Executive Vice President and Chief Business and Strategy Officer 12.02.2021 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 11.10.2021 Iveric Bio to Participate in the Stifel 2021 Virtual Healthcare Conference 11.09.2021 Iveric Bio Reports Third Quarter 2021 Operational Highlights and Financial Results 11.03.2021 Iveric Bio to Participate in the Credit Suisse 30th Annual Virtual Healthcare Conference 11.02.2021 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 11.02.2021 Iveric Bio to Report Third Quarter 2021 Financial Results and Host Conference Call on Tuesday, November 9, 2021 10.21.2021 Iveric Bio Announces Pricing of Upsized Public Offering of Common Stock Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
